Compound details
Quercetin 4\'-isobutyrate
| Compound ID | CDAMM01557 |
|---|---|
| Common name | Quercetin 4\'-isobutyrate | IUPAC name | [2-hydroxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenyl] 2-methylpropanoate |
| Molecular formula | C19H16O8 |
| Retention time | 6.46 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 373.087 | Theoretical mz | 373.092 |
| Error | 14.41 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1601 |
| Inchi key | RTGAIXBQQQCKJM-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(OC=1C=CC(=CC1O)C=2OC=3C=C(O)C=C(O)C3C(=O)C2O)C(C)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P00734 | F2 | Thrombin | T94033 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P02766 | TTR | Transthyretin | T86462 | SwissTargetPrediction and SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14555 | PLA2G2A | Phospholipase A2 group IIA | T19160 | SwissTargetPrediction |
| P04054 | PLA2G1B | Phospholipase A2 group 1B | T31479 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction and SEA |
| P00747 | PLG | Plasminogen | T89034 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction and SEA |
| P05164 | MPO | Myeloperoxidase | T23471 | SwissTargetPrediction and SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SwissTargetPrediction |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SwissTargetPrediction and SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SwissTargetPrediction and SEA |
| P35869 | AHR | Aryl hydrocarbon receptor | T23666 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | T56418 | SwissTargetPrediction |
| Q9HC97 | GPR35 | G-protein coupled receptor 35 | T56143 | SwissTargetPrediction and SEA |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SwissTargetPrediction and SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SwissTargetPrediction and SEA |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P11474 | ESRRA | Estrogen-related receptor alpha | T72841 | SwissTargetPrediction and SEA |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| O95271 | TNKS | Tankyrase-1 | T83059 | SwissTargetPrediction |
| P06213 | INSR | Insulin receptor | T85435 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SwissTargetPrediction and SEA |
| P18054 | ALOX12 | Arachidonate 12-lipoxygenase | T35527 | SwissTargetPrediction and SEA |
| P30518 | AVPR2 | Vasopressin V2 receptor (by homology) | T66237 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| Q96S37 | SLC22A12 | Solute carrier family 22 member 12 | T86057 | SwissTargetPrediction |
| P11387 | TOP1 | DNA topoisomerase I | T09826 | SwissTargetPrediction |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| Q05397 | PTK2 | Focal adhesion kinase 1 | T15068 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P51955 | NEK2 | Serine/threonine-protein kinase NEK2 | T49102 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SwissTargetPrediction |
| P25024 | CXCR1 | Interleukin-8 receptor A | T00884 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SwissTargetPrediction |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P49763 | PGF | Placenta growth factor | T70792 | SEA |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | T40694 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction and SEA |
| P14679 | TYR | Tyrosinase | T97035 | SwissTargetPrediction and SEA |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SwissTargetPrediction and SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SwissTargetPrediction and SEA |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SwissTargetPrediction and SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SwissTargetPrediction and SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SwissTargetPrediction and SEA |
| P30530 | AXL | Tyrosine-protein kinase receptor UFO | T82383 | SwissTargetPrediction |
| P51679 | CCR4 | C-C chemokine receptor type 4 | T06955 | SEA |
| Q16512 | PKN1 | Protein kinase N1 | T60003 | SwissTargetPrediction and SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SwissTargetPrediction |
| Q9HC98 | NEK6 | Serine/threonine-protein kinase NEK6 | T78992 | SwissTargetPrediction and SEA |
| O60285 | NUAK1 | NUAK family SNF1-like kinase 1 | T21653 | SwissTargetPrediction and SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SwissTargetPrediction and SEA |
| P05089 | ARG1 | Arginase-1 (by homology) | T63224 | SwissTargetPrediction |
| O75581 | LRP6 | Low-density lipoprotein receptor-related protein 6 | T49755 | SEA |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| Q9UK17 | KCND3 | Voltage-gated potassium channel Kv4.3 | T74500 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T19160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P14555 | PLA2G2A |
| T31479 | DI0230 | Leishmaniasis | [ICD-11: 1F54] | P04054 | PLA2G1B |
| T31479 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P04054 | PLA2G1B |
| T31479 | DI0367 | Rosacea | [ICD-11: ED90] | P04054 | PLA2G1B |
| T31479 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P04054 | PLA2G1B |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T89034 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00747 | PLG |
| T89034 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00747 | PLG |
| T89034 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P00747 | PLG |
| T89034 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00747 | PLG |
| T89034 | DI0345 | Procedure injury | [ICD-11: NE81] | P00747 | PLG |
| T89034 | DI0357 | Pulmonary thromboembolism | [ICD-11: BB00] | P00747 | PLG |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T23471 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P05164 | MPO |
| T23471 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P05164 | MPO |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T23666 | DI0351 | Psoriasis | [ICD-11: EA90] | P35869 | AHR |
| T23666 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35869 | AHR |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T56418 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T56418 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q9UM73 | ALK |
| T56418 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T72841 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P11474 | ESRRA |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T83059 | DI0060 | Brain cancer | [ICD-11: 2A00] | O95271 | TNKS |
| T83059 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O95271 | TNKS |
| T83059 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O95271 | TNKS |
| T83059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O95271 | TNKS |
| T85435 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P06213 | INSR |
| T85435 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P06213 | INSR |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T66237 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30518 | AVPR2 |
| T66237 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30518 | AVPR2 |
| T66237 | DI0131 | Enuresis | [ICD-11: 6C00] | P30518 | AVPR2 |
| T66237 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P30518 | AVPR2 |
| T66237 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30518 | AVPR2 |
| T66237 | DI0338 | Polyuria | [ICD-11: MF55] | P30518 | AVPR2 |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T86057 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q96S37 | SLC22A12 |
| T09826 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11387 | TOP1 |
| T09826 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11387 | TOP1 |
| T09826 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11387 | TOP1 |
| T09826 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P11387 | TOP1 |
| T09826 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11387 | TOP1 |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T15068 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q05397 | PTK2 |
| T15068 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q05397 | PTK2 |
| T15068 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | Q05397 | PTK2 |
| T15068 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | Q05397 | PTK2 |
| T15068 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q05397 | PTK2 |
| T15068 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05397 | PTK2 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T00884 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25024 | CXCR1 |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T70792 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P49763 | PGF |
| T40694 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P53350 | PLK1 |
| T40694 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P53350 | PLK1 |
| T40694 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P53350 | PLK1 |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T82383 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P30530 | AXL |
| T06955 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P51679 | CCR4 |
| T06955 | DI0379 | Sezary syndrome | [ICD-11: 2B02] | P51679 | CCR4 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T63224 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P05089 | ARG1 |
| T49755 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O75581 | LRP6 |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |
| T74500 | DI0004 | Acidosis | [ICD-11: 5C73] | Q9UK17 | KCND3 |